APA (7th ed.) Citation

Damele, L., Amaro, A., Serio, A., Luchetti, S., Pfeffer, U., Mingari, M. C., & Vitale, C. (2021). EZH1/2 Inhibitors Favor ILC3 Development from Human HSPC-CD34⁺ Cells. MDPI AG.

Chicago Style (17th ed.) Citation

Damele, Laura, Adriana Amaro, Alberto Serio, Silvia Luchetti, Ulrich Pfeffer, Maria Cristina Mingari, and Chiara Vitale. EZH1/2 Inhibitors Favor ILC3 Development from Human HSPC-CD34⁺ Cells. MDPI AG, 2021.

MLA (8th ed.) Citation

Damele, Laura, et al. EZH1/2 Inhibitors Favor ILC3 Development from Human HSPC-CD34⁺ Cells. MDPI AG, 2021.